Sysmex by the Numbers
Sysmex holds the No. 1 share of the global market in the hematology field (the field of in vitro diagnostics that determines whether precise testing is necessary by analyzing the number, type and size of red, white and other blood cells).
To ensure that accurate testing results are delivered swiftly, we provide products of high quality and high usability and offer extensive after-sales support.
Sysmex’s business is in the in vitro diagnostics field. We are an integrated manufacturer that conducts everything from R&D to manufacturing, sales and after-sales services on the instruments, reagents and software used to analyze blood, urine and cell specimens. We provide products and after-sales support to customers in more than 190 countries and regions around the world.
Circulating blood cells are too small to be seen with the naked eye. Sysmex helps people remain healthy through its technologies for measuring these blood cells, which have a diameter of around 2 micrometers. (One micrometer is one-millionth of a meter, or 0.001 millimeters.)
Nearly 100 years before automation in the field of hematology, healthcare professionals used microscopes to measure and count the number of blood cells. In 1963, Sysmex became the first company in Japan to achieve automation in hematology. Now, we have developed technology that allows for the automated counting of around 100,000 blood cells per second with higher testing precision and efficiency.
Sysmex provides medical instruments that are closely connected with people’s lives. For this reason, we have in place call centers for customer service contacts staffed with highly knowledgeable, dedicated staff that operate around the clock, 365 days a year.*1
In Japan and at our regional headquarters overseas, we provide call center support to our customers. We also provide network support services with real-time monitoring and remote maintenance.
- A separate agreement is required.
Disease states differ by person, so it is understood that the same treatment method may not be appropriate even for people with the same disease. In recent years, progress in genetic analysis technology has made it possible to determine optimal treatment methods for individual patients. Selecting the optimal treatment method can help reduce the physical burden on patients, as well as curtail medical expenses.
